Clarivate/$CLVT
1D1W1MYTD1Y5YMAX
Capital at risk
About Clarivate
Clarivate is a data, information, and software workflow solutions company serving customers primarily in academia, government, law, life sciences, and healthcare. The company was formerly part of Thomson Reuters before being sold to private equity as an independent company in 2016. In 2019, Clarivate went public on the New York Stock Exchange. Around half of the company's revenue is generated in the Americas, while Europe, Middle East, and Africa account for around a quarter.
- Ticker
- $CLVT
- Sector
- Business services
- Primary listing
- NYSE
- Employees
- 12,000
- Headquarters
- London, United Kingdom
- Website
- www.clarivate.com
Clarivate Metrics
BasicAdvanced
$1.2B
-
-$0.51
1.39
-
Price and volume
Market cap
$1.2B
Beta
1.39
52-week high
$4.14
52-week low
$1.66
Average daily volume
4.2M
Financial strength
Current ratio
0.846
Quick ratio
0.721
Long term debt to equity
0.934
Total debt to equity
0.938
Interest coverage (TTM)
0.65%
Profitability
EBITDA (TTM)
914.8
Gross margin (TTM)
66.82%
Net profit margin (TTM)
-13.84%
Operating margin (TTM)
6.81%
Effective tax rate (TTM)
1.33%
Revenue per employee (TTM)
$200,000
Management effectiveness
Return on assets (TTM)
0.94%
Return on equity (TTM)
-7.01%
Valuation
Price to revenue (TTM)
0.51
Price to book
0.27
Price to tangible book (TTM)
-0.27
Price to free cash flow (TTM)
3.753
Free cash flow yield (TTM)
26.64%
Free cash flow per share (TTM)
0.504
Growth
Revenue change (TTM)
-3.50%
Earnings per share change (TTM)
-17.27%
3-year revenue growth (CAGR)
-2.57%
3-year earnings per share growth (CAGR)
-56.82%
What the Analysts think about Clarivate
Analyst ratings (Buy, Hold, Sell) for Clarivate stock.
Analyst projections of the future price of Clarivate stock.
Bulls say / Bears say
Organic annual contract value grew 1.5% year-over-year in Q2 2026, driven by improved product pricing as Clarivate advances its subscription-led strategy. (SEC EDGAR)
Clarivate reduced its total debt outstanding by $218.4 million in the first half of 2026 through accelerated repayments and bond repurchases, strengthening its balance sheet. (SEC EDGAR)
Free cash flow for the first six months of 2026 was $122.9 million, supporting disciplined capital allocation and funding both debt reduction and strategic investments. (SEC EDGAR)
Total revenue fell 5.5% year-over-year to $587.3 million in Q2 2026, as lower transactional revenues and divestitures offset subscription gains. (Morningstar)
Clarivate recorded a GAAP net loss of $268.6 million in Q2 2026 due to a $221.7 million non-cash goodwill impairment related to its Life Sciences & Healthcare divestiture. (Morningstar)
Organic subscription revenue grew just 0.7% in Q2 2026, as modest subscription gains were outweighed by larger declines in other revenue segments, highlighting continued transactional headwinds. (Morningstar)
Data summarised monthly by Lightyear AI. Last updated on 25 Aug 2026.
Clarivate Financial Performance
Revenues and expenses
Clarivate Earnings Performance
Company profitability
Upcoming events
No upcoming events
Clarivate News
AllArticlesVideos
Funds containing Clarivate
AllEURGBPUSD
Fund name | Fund size | $CLVT weighting |
|---|---|---|
iShares MSCI USA Small Cap ESG Enhanced CTB€SXRG | €2.8B | 0.03% |
iShares MSCI USA Small Cap CTB Enhanced ESG£CUS1 | £2.4B | 0.03% |
SPDR Russell 2000 US Small Cap€R2US | €4.8B | 0.02% |
iShares MSCI World Small Cap$WSML | $9B | 0.01% |
iShares MSCI World Small Cap€IUSN | €7.8B | 0.01% |
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.